Joshua Zhang
ORCID: 0009-0000-0023-6329Also affiliated with Cornell University, Bristol-Myers Squibb (United States), National Center for Advancing Translational Sciences
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial”.
Thomas Powles, Bernard Escudier, Mauricio Burotto, Joshua Zhang, Burçin Şimşek +4 more
Tejas Subramanian, Chad Simon, Nishtha Singh, Takashi Hirase, Kasra Araghi +13 more
Chad Z. Simon, Atahan Durbas, Myles R.J. Allen, Kevin J. DiSilvestro, Takashi Hirase +19 more
Adrian Lui, Christopher Mikhail, Kyle W. Morse, Joshua Zhang, Cole Kwas +4 more